4月28日 - ** 汇丰银行将礼来LLY.N的评级从 "买入 "双双下调至 "减持 "后，礼来LLY.N的股价盘前下跌1.4%，至872.32美元。
** 券商还将目标价从1150美元下调至700美元，称 "价格过于乐观"。
** 汇丰称肥胖症药物行业对宏观环境敏感，失业率上升导致的行业增长风险尚不可知
** 汇丰银行补充道，"在当前股价下，我们更看好诺和诺德(Nordisk) 而不是礼来"。
** 券商还将罗氏ROG.S和百健BIIB.O的评级从 "买入 "下调至 "持有"，理由是罗氏面临外汇和中国诊断风险，百健在阿尔茨海默氏症领域的应用进展缓慢。
** 29位分析师中有23位将股票评级定为 "买入 "或更高，5位 "持有"，1位 "卖出"，PT中值为1000美元。
** 截至去年收盘，LLY 累计上涨 14.6%，ROG 累计上涨 3.6%，BIO 累计下跌 22.3
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.